# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-23-055992
Filing Date
2023-05-04
Accepted
2023-05-04 16:05:41
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | cldx-20230331x10q.htm iXBRL | 10-Q | 992412
2 | EXHIBIT 31.1 | cldx-20230331xex31d1.htm | EX-31.1 | 13783
3 | EXHIBIT 31.2 | cldx-20230331xex31d2.htm | EX-31.2 | 13788
4 | EXHIBIT 32.1 | cldx-20230331xex32d1.htm | EX-32.1 | 7344
| Complete submission text file | 0001104659-23-055992.txt |  | 4972317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20230331.xsd | EX-101.SCH | 30737
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20230331_cal.xml | EX-101.CAL | 39445
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20230331_def.xml | EX-101.DEF | 134843
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20230331_lab.xml | EX-101.LAB | 326956
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20230331_pre.xml | EX-101.PRE | 230185
54 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20230331x10q_htm.xml | XML | 968366

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 23888593
SIC: 2835 In Vitro & In Vivo Diagnostic Substances